The studies presented in this review demonstrate the development and research of drug candidates for the treatment of infectious and non-infectious diseases in the field of polypeptide furin inhibitors, covalent and non-covalent peptidomimetic furin inhibitors, including macrocyclic peptidomimetics and small molecules. Here, FURIN is linked to infectious disease.